In this episode, Matt sits down with recurring guest and Prime Health Associates founder Dr. Kevin White for an in-depth discussion on coronary artery health using the Cleerly exam: a cutting-edge, AI-driven coronary computed tomography angiogram (CTA). This tool provides an advanced assessment of cardiovascular risk by visualizing not only calcified plaque but also soft and low-density soft plaques, offering a proactive window into heart health long before symptoms arise.

Matt and Kevin begin by framing the Cleerly exam as a revolutionary diagnostic approach that fills a critical gap in cardiovascular screening. While traditional tests like stress tests or calcium scans often miss early disease, Cleerly’s AI analysis enables precise visualization of plaque buildup and composition. Kevin shares anecdotes from clinical practice, including the case of a fit, young man who suffered a heart attack despite outward signs of good health—illustrating the importance of early, detailed assessments like Cleerly for detecting hidden risks.

Matt shares his personal experience undergoing the Cleerly exam. Matt and Kevin discuss the low levels of radiation exposure involved in the Cleerly exam, comparing it to everyday environmental exposure and underscoring that the potential benefits of early detection far outweigh the risks for most individuals.

As they review Matt’s results, Kevin highlights a reassuringly low total plaque burden primarily composed of soft, non-calcified plaque. Although soft plaque can pose higher immediate risk due to its potential to rupture, it is also more amenable to lifestyle interventions. Matt, who has a family history of heart disease, had anticipated worse outcomes due to his past lifestyle but is relieved by the findings. The pair emphasize that Cleerly empowers patients to visualize their cardiovascular status in detail, arming them with the knowledge to take control of their health trajectory.

A key theme throughout is the importance of access to this data. Matt critiques the current limitation that only healthcare providers can access Cleerly’s full interactive portal, which includes rich 3D artery models and quantitative breakdowns. Both agree that engaged patients, especially those motivated to take charge of their health, should have direct access to these insights.

The episode also covers intervention strategies based on Cleerly results. and highlights that plaque accumulation is not a fixed outcome but a modifiable condition with the right interventions. We recommend this episode to anyone interested in longevity, preventive medicine, and the growing role of AI in healthcare diagnostics.